Table:
Characteristics	Total N (%)
Age
50-59	14 (17)
60-69	27 (33)
70-79	24 (30)
80-89	16 (20)
Gender
Male	34 (41)
Female	45 (54)
Tumor Location
Right	52 (63)
Left	31 (37)
Stage
I and II	54 (65)
III	29 (35)
MMR status
MSS	55 (67)
MSI-H	27 (33)
Chr.17p allelic state
AB	39 (47)
LOH	9 (11)
CNLOH	11 (13)
ALOH	7 (8)
AI	3 (4)
Multiple clones	14 (17)
DNA index
0.95 – 1.05	35 (46)
1.06 – 1.40	10 (13)
1.41 – 1.95	31 (41)
TP53
wt	22 (55)
mut	18 (45)
IHC p53
0 %	10 (13)
>0% - ≤25%	35 (46)
>25%	31 (41)
Median Follow up in months (range)	68.84 (2–199)

Parse the image content behind with markdown code: | Characteristics | Total N (%) | 
 | --- | --- | 
 | Age |  | 
 | 50-59 | 14 (17) | 
 | 60-69 | 27 (33) | 
 | 70-79 | 24 (30) | 
 | 80-89 | 16 (20) | 
 | Gender |  | 
 | Male | 34 (41) | 
 | Female | 45 (54) | 
 | Tumor Location |  | 
 | Right | 52 (63) | 
 | Left | 31 (37) | 
 | Stage |  | 
 | I and II | 54 (65) | 
 | III | 29 (35) | 
 | MMR status |  | 
 | MSS | 55 (67) | 
 | MSI-H | 27 (33) | 
 | Chr.17p allelic state |  |


 | AB | 39 (47) | 
 | LOH | 9 (11) | 
 | CNLOH | 11 (13) | 
 | ALOH | 7 (8) | 
 | AI | 3 (4) | 
 | Multiple clones | 14 (17) | 
 | DNA index |  | 
 | 0.95 – 1.05 | 35 (46) | 
 | 1.06 – 1.40 | 10 (13) | 
 | 1.41 – 1.95 | 31 (41) | 
 | TP53 |  | 
 | wt | 22 (55) | 
 | mut | 18 (45) | 
 | IHC p53 |  | 
 | 0 % | 10 (13) | 
 | >0% - ≤25% | 35 (46) | 
 | >25% | 31 (41) | 
 | Median Follow up in months (range) | 68.84 (2–199) |